Statement
5 Jun 2023
G20 side event on Global Vaccine Research Collaborative
On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read more
Statement
8 May 2023
IFPMA statement for Multi-stakeholder Hearing on Tuberculosis
On 8 may, IFPMA read the following statement at the Multi-stakeholder Hearing on Tuberculosis (TB) in New York.
Read more
Position paper
27 Mar 2023
No-Fault Compensation (NFC) systems and legislative liability protections for pandemic vaccines
This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.
Read more
